Outside of Western Europe, Canada, New Zealand, Australia and South Africa, birth control is frequently available prescription-free \u2014 even in conservative countries<\/a> like Saudi Arabia, Turkey or Indonesia.<\/p>\n In the United States, where reproductive rights are often hotly contested, birth control has been available prescription-free<\/a> since 2023.<\/p>\n So why does Canada still lag behind? The answer is more complicated than you might think.<\/p>\n Common side effects<\/p>\n Since 1960, the majority of oral birth control methods are so-called \u201ccombined pills\u201d \u2014 combinations of the hormones estrogen and progestin, which prevent the ovaries from releasing eggs.<\/p>\n These pills, which include common consumer products like Yasmine, come with some side effects, such as bloating and headaches, and risks, such as cervical cancer or blood clots.<\/p>\n These risks start small, but increase<\/a> among older women. That\u2019s one reason, doctors say, why ongoing monitoring by medical professionals is often recommended.<\/p>\n Dr. Wendy Norman, a family physician and researcher in sexual health at the University of British Columbia, says that\u2019s why only places with a higher tolerance for medical risk \u2014 usually developing countries \u2014 tend to allow prescription-free access to the combined pill.<\/p>\n \u201cThere\u2019s no medical system in the world where malpractice would be [seriously] considered \u2026 that they will not regulate medications containing estrogen,\u201d said Norman.<\/p>\n Better options available<\/p>\n But many of the prescription-free birth control options that have recently entered the global market no longer rely on estrogen.<\/p>\n Progestin-only pills \u2014 like Opill<\/a> \u2014 work by thickening the mucus in the cervix so that sperm cannot get through to fertilize an egg. Most, but not all, women also stop producing eggs altogether, as with a traditional birth control pill.<\/p>\n Taking these pills requires more discipline: the margin of error for when you take a pill is narrower. But, they are much safer to take without any monitoring from a physician or pharmacist.<\/p>\n \u201cThe progestin-only pill has very few contraindications,\u201d said Dr. Amanda Black, president of the Society of Obstetricians and Gynecologists of Canada.<\/p>\n Some of these pills are already available in Canada, and \u201ccould probably be offered without a prescription,\u201d said Black. But it\u2019s not quite so simple.<\/p>\n Drug companies must request that their product be made available without a prescription when registering it with Health Canada. So far, no companies have done so \u2014 and it doesn\u2019t seem like it\u2019s part of their plan.\u00a0<\/p>\n Black named Slynd, a progestin-only pill approved for sale in Canada in 2021, as a great potential candidate for over-the-counter sale, alongside generic variants like Movisse.<\/p>\n But Duschesnay Canada, the developer of Slynd, said they wouldn\u2019t be requesting prescription-free status.<\/p>\n \u201cOur business model is centered on prescription medications,\u201d a spokesperson said via email.<\/p>\n That may be because of stringent requirements to get a drug approved for prescription-free status.<\/p>\n To approve a drug for over-the-counter sale, Health Canada must be convinced \u201cthat the product is appropriate for use without the involvement of a health-care practitioner,\u201d according to a spokesperson for the agency.<\/p>\n That sounds easy enough \u2014 but Black says it can involve expensive requirements for complex medical trials. Data from other countries where similar products are already widely sold is rarely, if ever, accepted.<\/p>\n \u201cThey had to have a clinical trial in Canada,\u201d she said, \u201cand that clinical trial had to include endometrial biopsy\u201d \u2014 an invasive procedure where a tissue sample is taken from the uterus.<\/p>\n Under such requirements, Black says it\u2019s hard to even find enough willing participants in Canada \u2014 much less justify the expense.<\/p>\n \u201cThe companies said, we\u2019re not going to do that, because there isn\u2019t the market.\u201d<\/p>\n Norman, the sexual health researcher, says there are some upsides to keeping birth control prescription-only.<\/p>\n \u201cIf you have a medication that is on prescription, then the health system will pay for it,\u201d she said.<\/p>\n Norman played a key role advocating for including free contraception in the national pharmacare plan, which she says will increase access across the country, regardless of income. She says making birth control prescription-free could jeopardize that.<\/p>\n \u201cThe health system does not [generally] pay for non-prescription drugs,\u201d she said.<\/p>\n But despite that plan being introduced nearly two years ago, most provinces and territories still don\u2019t offer free contraception<\/a>. And in the meantime, requiring prescriptions may be doing more harm than good.<\/p>\n Kelly Blanchard, who works with Norman on a campaign called Free the Pill aimed at improving contraceptive access, says prescription requirements present a steep barrier to many women.<\/p>\n![\"A](\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/02\/1770547808_418_default.jpg\")
Dr. Wendy Norman, a UBC sexual health researcher, works on a project called Free the Pill to improve contraceptive access in Canada. (Submitted by Wendy Norman)<\/p>\n![\"A](\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/02\/1770547808_956_default.jpg\")
Dr. Amanda Black, president of the Society of Obstetricians and Gynecologists of Canada, says some oral contraceptives could be made prescription-free. (Submitted by the SOGC)<\/p>\n![](\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/02\/1770547808_226_default.jpg\")
Health Canada currently requires a prescription for oral contraceptives and approving them for over-the-counter sale could prove expensive and time-consuming for companies. (Sean Kilpatrick\/Canadian Press )Big barriers for businesses<\/p>\n![\"The](\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/02\/1770547809_117_default.jpg\")
In Canada, companies must request that a product be made available for over-the-counter sale. Pharmaceutical companies like Bayer AG, which makes Yasmine, and Duschesnay Canada, which makes Slynd, have no plans to do so. (Ina Fassbender\/Reuters)Patient care, or patriarchy?<\/p>\n![\"A](\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/02\/1770547809_896_default.jpg\")
Kelly Blanchard is the president of Ibis Reproductive Health, which runs the day-to-day operations of Free the Pill, a campaign to educate and engage the public in support of over-the-counter birth control (Submitted by Ibis Reproductive Health)<\/p>\n
![\"\"](\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/02\/1770547810_464_default.jpg\")
<\/p>\n